Press release BoxID: 671593 (ISPE Europe)
  • ISPE Europe
  • Avenue de Tervueren 300
  • 1150 Brüssel
  • Contact person
  • Paulina Santiago
  • +32 (2) 74323-05

A unique opportunity to contribute to a pan-European initiative to reduce drug shortages

ISPE Europe Annual Conference, 28 - 30 April, 2014 - Frankfurt, Germany

(PresseBox) (Brüssel , ) Following ISPE's 2013 Drug Shortages Survey and the Society's commitment to seek best-practice solutions to the problems identified, ISPE today announces a line-up of activities that will bring pharmaceutical industry stakeholders together at its first European annual conference to be held at the end of this month in Frankfurt, a unique collaboration aimed at addressing issues leading to shortages in the European drug supply.

Beginning Monday 28th April 2014 the executive forum will bring together representatives from all the associations contributing to an Inter-Association task force that is responding to the European Medicines Agency request to submit to them a report on how shortages resulting from manufacturing problems could be prevented. This task force, moderated by ISPE, will include representatives from the Parenteral Drug Association, the Plasma Protein Therapeutics Association, and European trade associations representing innovator, generic and self-medication industries. Additionally, the European trade associations will report on their complimentary project on ideas to improve the communication of shortages. A question and answer session which includes Brendan Cuddy (EMA) and regulators from national authorities will enable delegates to gain further insight into the initiatives and provide their input into the projects.

In the main conference session, on Wednesday April 30th, there will be more extensive presentations from each of the stakeholders, together with national competent authorities, on the activities that their organisations are pursuing and contributing to the EMA's request. An extensive panel discussion with industry and regulatory representatives will provide further opportunities to influence the course of the shortages projects, further areas for follow-up research, and pathways to improving processes that could mitigate or avoid shortages.

The ISPE Europe Annual Conference provides the one opportunity in Europe during 2014 to contribute to interactive discussion sessions on this ground-breaking, multi-association collaborative effort to address manufacturing and quality problems that have the potential to deny patients access to critical medicines.

For more information on this conference, including detailed agendas and registration information, visit:

ISPE Europe

ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA. Visit for more information.